THE LIGHT POWER
The most common and less serious forms of skin cancer are basal cell and squamous cell carcinomas. These cutaneous carcinomas most often affect people with white skin over 40 years of age, but can sometimes also occur in younger people.
MEDELISOL® High-Power LED dynamic phototherapy makes use of a photosensitizing substance that is applied to the skin before exposing it to a specific light.
The substance is applied to skin in the form of a liquid or cream containing aminolevulinic acid (5-ALA-HCL) or methyl aminolevulinate (MAL). These photosensitizing substances are more readily absorbed by diseased tissue.
Exposure to the light emitted by the MEDISOL® High-Power LED lamp activates the substance, hence specifically destroying the tissues that have absorbed it.